Bill Densel

William Densel currently works at Temple Therapeutics BV, as Chief Operating Officer.
Mr. Densel also formerly worked at Dune Medical Devices Ltd., as Chief Executive Officer from 2010 to 2011, Check-Cap Ltd., as Chief Executive Officer & Director from 2015 to 2018, Beacon Endoscopic, Inc., as Chief Executive Officer from 2013 to 2014, Check-Cap US, Inc., as President, Chief Executive Officer & Director from 2015 to 2018, Boston Scientific Corp., as Director-New Market Development from 2004 to 2006, Genzyme Biosurgery Corp., as Senior Director-Marketing & Business Development from 1993 to 2004, Hologic, Inc., as Vice President-Marketing, Cytyc Corp., as Vice President-Marketing from 2006 to 2009, Genzyme Corp., as Principal, and BG Medicine, Inc., as General Manager-CardioSCORE from 2012 to 2013.
Mr. Densel received his undergraduate degree from Duke University.